Upcoming Meetings: In Vitro Diagnostics Roundtable
This article was originally published in The Gray Sheet
In Vitro Diagnostics Roundtable: FDA/industry group collaborating on IVD issues schedules Nov. 18 workshop to discuss preparation of 510(k) submissions for diagnostic devices. The meeting will be held at FDA's Baltimore district office; for registration information, contact Becton Dickinson's Zenia Ambrose at 410/316-4260. The IVD Roundtable consists of staffers from the premarket review and compliance offices in FDA's device and biologics centers as well as industry reps. The group has met quarterly since its formation in late 1995...
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.